+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07251530

Using the JIB-Tours Care Eye-Tracking Tablet to Help Communication for Ventilated Patients in Intensive Care

Led by University Hospital, Tours · Updated on 2026-05-04

60

Participants Needed

3

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Patients in intensive care who require mechanical ventilation often face severe challenges, including difficulty moving and communicating due to intubation or tracheostomy. Many experience anxiety and complications like post-intensive care syndrome, with current communication tools being ineffective. This study aims to implement a personalized communication device to assist ventilated patients in intensive care. The device under evaluation, called JIB-Tours care, uses a tablet with eye-tracking technology to allow patients to communicate through gaze control. It first assesses the patients understanding by analyzing eye movements, then automatically adjusts to one of three communication interfaces suited to their level. This device was developed collaboratively with healthcare professionals, former patients, and their families to improve communication. Participants will use the device in the intensive care unit, where researchers will assess how successfully it can be set up and used to deliver patient messages. Various outcomes will be measured, including the success rate of device use, setup time, communication effectiveness, user satisfaction, and feedback for improvement. The study includes evaluations on the first day and follow-up feedback on day 28, with participation lasting through these assessments.

CONDITIONS

Brief Title

Communication Enhancement Among Ventilated Patients in Intensive Care

Research Team

L

Laetitia BODET-CONTENTIN, Doctor

A

Adrien LOCICIRO, nurse

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here